top of page


As Netra introduces new investors to the exciting world of early-stage health startups, we place a strong emphasis on equipping them to make informed decisions. We understand that exploring this area, especially if you are not familiar with its nuances, can be both exciting and challenging. Our commitment lies in bridging the knowledge gap and providing valuable insights that demystify the process through our BrainTrust articles. We strive to provide novice investors with the information, support, and community they need to make educated investment decisions through the use of our extensive resources, expert guidance, and welcoming environment. We hope that by promoting open communication and education, a new generation of astute investors will be developed who will aid in the development and success of cutting-edge healthcare ventures. Join us in this educational journey, where your curiosity and eagerness to learn are the cornerstones of informed investment.


BrainTrust #1: Can AI and MRI Join Forces to Combat Alzheimer's?

by Manan Atit and Puneet Gupta with guest author Shreyan Ghelani

Alzheimer's disease casts a long shadow across society, with its impact expected to grow significantly, driven primarily by a growing population of older adults. While ground-breaking therapeutic solutions are on the horizon, early diagnosis and personalized care remain critical in the fight against this devastating disease. This is where this past Friday’s de novo approval by the FDA for Darmiyans BrainSee sparked a discussion on the current state of managing this disease at Netra Health. This innovative software, analyzing brain MRIs alongside cognitive assessments through artificial intelligence, holds the potential to predict the progression of Amnestic Mild Cognitive Impairment (aMCI) to Alzheimer's dementia up to five years in advance.
How disruptive will BrainSee be in the early detection of Alzheimer's disease? Netra Health offers an overview of the emerging landscape, discusses important considerations as the field matures, and breaks down the context. Investing in these technologies comes with a caveat: structural, ethical, and market adoption hurdles could impact potential returns. But for investors with the vision and patience to navigate these challenges, the rewards could be substantial.

#NetraHealth #BrainSee #Alzheimer’s #medicalinnovation #disruptiveinnovation #GUIDE


BrainTrust #2: Summa Health and HATCo: First Domino in a Shift to Healthcare Assurance?

by Manan Atit and Puneet Gupta with guest author German Galaso

Netra Health had a chance to connect with German Galaso to talk about the acquisition of Summa Health by HATCo, and the context and implications for the industry. This article, aimed at investors navigating the complexities of such transformative events, explores the partnership's ambitious vision, potential, and hurdles that it must cautiously navigate. Feel free to share your insights as well. 

#Healthcare Assurance #Summa Health #HATCo #General Catalyst #Netra Health


BrainTrust #3: Gene Therapy Whispers Hope, Reshaping the Therapeutic Landscape

by Manan Atit and Puneet Gupta

Recent advancements in gene therapy offer a glimpse into a future where genetic disorders might be treated and potentially cured, not just managed. This Braintrust article from #NetraHealth explores the field's progress, focusing on the recent, successful use of gene therapy to treat hereditary hearing loss.

Article discusses:
💉 First successful US gene therapy: A young boy with OTOF-mediated hearing loss regained partial hearing after receiving a healthy copy of the missing gene directly to his inner ear
👨‍⚕️ Expanding beyond rare diseases: Gene therapy holds promise for various genetic conditions, including cystic fibrosis, muscular dystrophy, and even cancer
🚧 Challenges and considerations: Delivery methods, cost, long-term effects, and equitable access must be addressed for wider adoption
📈 Ripple effects on healthcare: Gene therapy may reshape medical device and pharmaceutical landscapes

#genetherapy #healthcare #innovation #futureofmedicine #hearingloss #NetraHealth #Lilly #Akouos #CHOP


BrainTrust #4: Investing 💰 + ⌛ + 💡: A New Engagement between Healthcare Professionals and Startups

by Manan Atit and Puneet Gupta with guest authors Jason Adams and Steve Gutterman 

The landscape of healthcare innovation is shifting. Traditionally, a select few KOLs drove innovation, but the rapid pace of change demands a wider net. This article proposes empowering the broader HCP community through advising, investing, and forging partnerships with promising startups. Excited to hear thoughts from others?

Thanks Jason Adams and Steve Gutterman of The Doctors Group for the collaboration this.

#braintrust #netrahealth #thedoctorgroup #healthcareinnovation #healthcareprofessionals #physicianpartnership #medtechinvestment #preIPOinvesting #empowerdoctors #impactinvesting #collectivestrength #doctors #physician


BrainTrust #5: Bridging the Gap: Sports Fueling Precision Medicine: The Modern Data-Driven Revolution

by Manan Atit and Puneet Gupta with guest author Maulik Purohit

Imagine healthcare as precise and personalized as the training regimen of a top athlete. This is the future we're consider by leveraging sports science. This article explores how insights from "The Rays Way" in baseball and other advancements are laying the groundwork for a potential healthcare revolution.
We'll dive into the exciting world of personalized health with leaders like #Oura and #SpringbokAnalytics, who are using cutting-edge technology to assess your individual health and unlock your full potential.
But it's not just about peak performance! We'll also explore how companies like #STATSports and #Plantiga are using data to detect injuries before they sideline you, and how #BioIntelliSense are pioneering new frontiers in recovery.

Thanks Maulik P. Purohit, MD, MPH for co-writing this article. Remember to sign up for the BrainTrust newsletter (and thank you for the support).

#BrainTrust #Healthcare #SportsTech #personalizedmedicine #AI #NetraHealth #DIATInsights  #digitalhealth


BrainTrust #6: Personalized Medicine in 2024: Navigating 2 IPOs, 1 Bankruptcy, and the Resulting Road Ahead

by Manan Atit and Puneet Gupta

The world of personalized medicine is in the spotlight in 2024 in this Braintrust article. Netra looks into advancements like IPOs for companies like Metagenomi (genome editing) and Alto Neuroscience (precision neurology). However, the story is balanced by former high flyer - Invitae, a former leader, who recently filed for bankruptcy. Give us your thoughts.

#personalizedmedicine #healthcare #futureofmedicine #genomics #genetics #AI #bigdata #precisionmedicine #innovation #healthcarestartup #biotech #Invitae #Metagenomi #AltoNeuroscience #IPO #clinicaltrials #drugdiscovery #NetraHealth #Braintrust


BrainTrust #7: Medtech's Agile Transformation: Accelerating Patient-Centered Innovation

by Manan Atit and Puneet Gupta and guest author Vivek Kulkarni

Traditionally slower to market due to rigorous development, medtech is in the midst of a shift towards faster, more efficient innovation. This article highlights Agile's and Critical Chain Methodologies' impact, from cutting development times to enhancing patient care. Comparing medtech to other regulated sectors like spacetech or automotive, discover how these methodologies can accelerate innovation and also align more closely with patient needs. Dive into a transformative approach where rapid prototyping and continuous feedback are reshaping the future of healthcare.

#BrainTrust #Healthcare #Innovation #Agile  #MedTech #Agile #PatientCare #DigitalHealth #MedtechInnovation #AgileTransformation #PatientCenteredCare #DigitalHealth #HealthTech #MedicalDevices #InnovationInHealthcare #RegulatoryCompliance #UserExperience #HealthcareTechnology #CriticalChain

bottom of page